Cargando…
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Parkinson's disease is a progressive neurodegenerative disease characterized by the loss of dopaminergic neurons of the nigrostriatal pathway and the formation of neuronal inclusions known as Lewy bodies. Chronic neuroinflammation, another hallmark of the disease, is thought to play an importan...
Autores principales: | Belarbi, Karim, Cuvelier, Elodie, Bonte, Marie-Amandine, Desplanque, Mazarine, Gressier, Bernard, Devos, David, Chartier-Harlin, Marie-Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568394/ https://www.ncbi.nlm.nih.gov/pubmed/33069254 http://dx.doi.org/10.1186/s13024-020-00408-1 |
Ejemplares similares
-
Trends in Glucocerebrosides Research: A Systematic Review
por: Desplanque, Mazarine, et al.
Publicado: (2020) -
NADPH oxidases in Parkinson’s disease: a systematic review
por: Belarbi, Karim, et al.
Publicado: (2017) -
A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer’s Disease
por: El Idrissi, Fatima, et al.
Publicado: (2021) -
Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
por: Cuvelier, Elodie, et al.
Publicado: (2018) -
Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
por: Wallom, Kerri-Lee, et al.
Publicado: (2021)